[1]羊海峰.胸腺五肽联合抗结核方案对老年肺结核患者症状改善及免疫功能的影响[J].医学信息,2022,35(07):168-170.[doi:10.3969/j.issn.1006-1959.2022.07.044]
　YANG Hai-feng.Effect of Thymopentin Combined with Antituberculosis Regimen on Symptom Improvement and Immune Function in Elderly Patients with Pulmonary Tuberculosis[J].Medical Information,2022,35(07):168-170.[doi:10.3969/j.issn.1006-1959.2022.07.044]
点击复制

胸腺五肽联合抗结核方案对老年肺结核患者症状改善及免疫功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年07期
页码:
168-170
栏目:
药物与临床
出版日期:
2022-04-01

文章信息/Info

Title:
Effect of Thymopentin Combined with Antituberculosis Regimen on Symptom Improvement and Immune Function in Elderly Patients with Pulmonary Tuberculosis
文章编号:
1006-1959（2022）07-0168-03
作者:
羊海峰
（盱眙县人民医院感染科，江苏 盱眙 211700）
Author(s):
YANG Hai-feng
(Department of Infection,Xuyi County People’s Hospital,Xuyi 211700,Jiangsu,China)
关键词:
肺结核; 抗结核方案; 胸腺五肽; 免疫功能; 炎性因子
Keywords:
Pulmonary tuberculosis; Antituberculosis regimen; Thymopentin; Immune function; Inflammatory factors
分类号:
R521
DOI:
10.3969/j.issn.1006-1959.2022.07.044
文献标志码:
A
摘要:
目的 探讨胸腺五肽联合抗结核方案对老年肺结核患者症状改善及免疫功能的影响。方法 选择2018年10月-2021年5月盱眙县人民医院收治的65例老年肺结核患者，按照入院顺序尾数的单双数分为常规组（n=32）和联合组（n=33）。常规组应用抗结核方案治疗，联合组在常规组基础上联合胸腺五肽治疗，比较两组免疫功能[T淋巴细胞亚群-3+（CD3+）、CD4+、CD4+/CD8+、免疫球蛋白-G（IgG）]、症状改善情况（痰菌转阴率、病灶吸收率及空洞闭合率）、血清炎性因子[白细胞介素-6（IL-6）、转化生长因子-β（TGF-β)、单核细胞趋化蛋白-1（MCP-1）]及不良反应发生率。结果 治疗后，联合组CD3+、CD4+、CD4+/CD8+、IgG水平高于常规组，差异有统计学意义（P＜0.05）；联合组痰菌转阴率、病灶吸收率及空洞闭合率高于常规组，但差异无统计学意义（P＞0.05）；联合组IL-6、TGF-β、MCP-1低于常规组，差异有统计学意义（P＜0.05）；联合组不良反应发生率与常规组比较，差异无统计学意义（P＞0.05）。结论 胸腺五肽联合抗结核方案治疗老年肺结核的效果确切，可促进患者症状改善，降低血清炎性因子水平，且对机体免疫功能影响小，用药安全性高。
Abstract:
Objective To investigate the effect of thymopentin combined with anti-tuberculosis regimen on symptom improvement and immune function in elderly patients with pulmonary tuberculosis.Methods A total of 65 elderly patients with pulmonary tuberculosis admitted to Xuyi County People’ s Hospital from October 2018 to May 2021 were selected and divided into routine group (n=32) and combined group (n=33) according to the single and double number of admission order tails. The conventional group was treated with antituberculosis regimen, and the combined group was treated with thymopentin on the basis of the conventional group. The immune function [T lymphocyte subsets-3+(CD3+), CD4+, CD4+/CD8+, immunoglobulin-G (IgG)], symptom improvement (sputum negative conversion rate, lesion absorption rate and cavity closure rate), serum inflammatory factors [interleukin-6 (IL-6), transforming growth factor-β (TGF-β), monocyte chemoattractant protein-1 (MCP-1)] and incidence of adverse reactions were compared between the two groups.Results After treatment, the levels of CD3+, CD4+, CD4+/CD8+ and IgG in the combined group were higher than those in the conventional group, and the difference was statistically significant (P<0.05). The sputum negative conversion rate, lesion absorption rate and cavity closure rate in the combined group were higher than those in the conventional group, but the difference was not statistically significant (P>0.05). The levels of IL-6, TGF-β and MCP-1 in the combined group were lower than those in the conventional group, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the combined group and the conventional group (P>0.05).Conclusion Thymopentin combined with anti-tuberculosis regimen is effective in the treatment of elderly pulmonary tuberculosis, which can promote the improvement of patients ’ symptoms, reduce the level of serum inflammatory factors, have little effect on the immune function of the body, and have high medication safety.

参考文献/References:

[1]中华医学会,中华医学会临床药学分会,中华医学会杂志社,等.肺结核基层合理用药指南[J].中华全科医师杂志,2020,19(10):891-899. [2]曹瑛,马天丽,李俊,等.胸腺肽α1辅助治疗复治肺结核合并糖尿病对痰结核菌阴转率、T淋巴细胞亚群、PCT、sTREM-1、TFN-γ的影响[J].河南预防医学杂志,2021,32(6):478-482.[3]Ahmed Mustafa GM,Yassin ME,Shami A,et al.Screening of Human Immunodeficiency Virus (HIV) among Newly Diagnosed Tuberculosis Patients in Eastern Sudan[J].Pol J Microbiol,2021,70(2):201-206. [4]刘国标,谭守勇,林晓珊,等.200例初治菌阳肺结核患者一线抗结核药物治疗后不良反应分析[J].结核病与肺部健康杂志,2015(4):228-232.[5]桑杨,刘云,张少毅.肺结核患者血清糖类抗原125、铁蛋白水平及营养状况的研究[J].贵州医药,2021,45(4):545-546.[6]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.肺结核基层诊疗指南(2018年)[J].中华全科医师杂志,2019,18(8):709-717. [7]董文雅,魏文静,谭卫国,等.常规抗结核化疗对肺结核患者痰液菌群的影响[J].实用医学杂志,2021,37(3):336-342. [8]Junaid M,Li CD,Li J,et al.Structural insights of catalytic mechanism in mutant pyrazinamidase of Mycobacterium tuberculosis[J].J Biomol Struct Dyn,2021,39(9):3172-3185. [9]陈永宏,肖江峰,陈瑞华,等.抗肺结核治疗患者血清炎症因子动态变化[J].中华医院感染学杂志,2020,30(21):3293-3296. [10]谢祎,韩晶,于维莉,等.天津市肺结核患者短程督导治疗期抗结核治疗效果及死亡影响因素分析[J].中国公共卫生,2020,36(1):126-129. [11]高敏,宋晓燕.抗结核药物对肺结核合并乙型肝炎患者肝功能及HBV-DNA水平的影响[J].临床和实验医学杂志,2019,18(24):2652-2655. [12]刁利霞,吴宇平,邓俊亮.胸腺五肽联合常规抗结核化疗方案在复治涂阳肺结核治疗中的应用[J].海南医学,2021,32(7):892-894. [13]Palisson A,Courcoul A,Durand B.Role of Cattle Movements in Bovine Tuberculosis Spread in France between 2005 and 2014[J].PLoS One,2016,11(3):e0152578. [14]孟素华.莫西沙星联合胸腺五肽对肺结核患者痰上清液细胞因子水平的影响[J].河北医药,2020,42(6):900-902,906. [15]罗瑾,张杰.强化营养支持辅助胸腺五肽治疗复治涂阳重症肺结核患者的近期疗效和对炎性细胞因子及免疫功能的影响[J].临床和实验医学杂志,2019,18(23):2524-2527. [16]杨才勇,李奎,江自成,等.胸腺五肽联合抗结核药治疗复治涂阳肺结核疗效观察[J].海南医学,2019,30(19):2539-2541.

相似文献/References:

[1]刘德福.肺结核患者痰中结核分枝杆菌检验的临床价值分析[J].医学信息,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
　LIU De-fu.Clinical Value Analysis of Mycobacterium tuberculosis in Sputum of Patients with Pulmonary Tuberculosis[J].Medical Information,2018,31(07):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
[2]马 萌.健康咨询服务对肺结核知识知晓率的影响分析[J].医学信息,2018,31(06):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
　MA Meng.Analysis of the Influence of Health Counseling Service on Knowledge Awareness Rate of Pulmonary Tuberculosis[J].Medical Information,2018,31(07):160.[doi:10.3969/j.issn.1006-1959.2018.06.057]
[3]徐 伦.2010-2020年大连金普新区肺结核流行病学调查分析[J].医学信息,2022,35(09):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
　XU Lun.Epidemiological Survey of Pulmonary Tuberculosis in Jinpu New District of Dalian from 2010 to 2020[J].Medical Information,2022,35(07):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
[4]艾苗苗.肺结核的发病现状及有效预防控制策略分析[J].医学信息,2018,31(16):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
　AI Miao-miao.Analysis of the Current Situation of Tuberculosis and Effective Prevention and Control Strategy[J].Medical Information,2018,31(07):90.[doi:10.3969/j.issn.1006-1959.2018.16.026]
[5]李新刚.抗结核药物治疗所致肝损伤患者的危险因素及其治疗转归观察[J].医学信息,2019,32(03):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
　LI Xin-gang.Risk Factors and Treatment Outcomes of Patients with Liver Injury Caused by Anti-tuberculosis Drugs[J].Medical Information,2019,32(07):155.[doi:10.3969/j.issn.1006-1959.2019.03.051]
[6]刘 杰.静脉注射利福平治疗老年肺结核的疗效[J].医学信息,2019,32(18):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
　LIU Jie.Efficacy of Intravenous Rifampicin in the Treatment of Senile Pulmonary Tuberculosis[J].Medical Information,2019,32(07):142.[doi:10.3969/j.issn.1006-1959.2019.18.048]
[7]肖 勇,欧富华,况 杰.2013~2017年南昌市学生肺结核流行特征及防制措施[J].医学信息,2019,32(20):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
　XIAO Yong,OU Fu-hua,KUANG Jie.Epidemiological Characteristics and Control Measures of Tuberculosis among Students in Nanchang City from 2013 to 2017[J].Medical Information,2019,32(07):116.[doi:10.3969/j.issn.1006-1959.2019.20.035]
[8]宋国锋.降钙素原检测诊断肺结核合并肺部细菌感染的价值[J].医学信息,2020,33(02):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
　SONG Guo-feng.Value of Procalcitonin Detection in Diagnosis of Pulmonary Tuberculosis with Pulmonary Bacterial Infection[J].Medical Information,2020,33(07):179.[doi:10.3969/j.issn.1006-1959.2020.02.058]
[9]丁 媛.PCT及CPR鉴别社区获得性肺炎和肺结核诊断的价值[J].医学信息,2020,33(03):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
　DING Yuan.Value of PCT and CPR in the Diagnosis of Community-acquired Pneumonia and Tuberculosis[J].Medical Information,2020,33(07):173.[doi:10.3969/j.issn.1006-1959.2020.03.058]
[10]丁 媛.血清ADA水平和T-spot.TB联合检测在肺结核诊断中的应用[J].医学信息,2020,33(05):171.[doi:10.3969/j.issn.1006-1959.2020.05.058]
　DING Yuan.Application of Combined Detection of Serum ADA Level and T-spot.TB in Diagnosis of Tuberculosis[J].Medical Information,2020,33(07):171.[doi:10.3969/j.issn.1006-1959.2020.05.058]

更新日期/Last Update: 1900-01-01